
Building Drug Discovery Workflows for the Next Generation of Therapeutics
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQdURoa05mUk1vcEsxZ19PQlQxd0pCbjM5b2lGM1l4SXpVRnZMSzBDR2h5TXQ5WXZlT0FkZ2JPVzc3T2VWLTdwUW13N3VUZXI0OVFMaGk4Z3JrOEI5blg1RmVjZXJibjlMS2RhVGlXM1pXaHBVTGpjQXJVX1FiQ0Z3ZUt6bnpQUXRPSGhLOHk4SWdDSU10RDhjaDdJMEhhcElvbVpWUUlOQ3hwQQ?oc=5" target="_blank">Building Drug Discovery Workflows for the Next Generation of Therapeutics</a>&nbsp;&nbsp;<font color="#6f6f6f">Lab Manager</font>

![[BIO USA] Samsung Biologics Eyes CGT and Peptides... CDMO Big 3 Compete to Lead Next-Generation Modality Market](/_next/image?url=%2Fimages%2Fmarket-default.png&w=3840&q=75)
